Viewing Study NCT05819866


Ignite Creation Date: 2025-12-24 @ 4:42 PM
Ignite Modification Date: 2025-12-30 @ 5:25 AM
Study NCT ID: NCT05819866
Status: RECRUITING
Last Update Posted: 2025-11-17
First Post: 2023-03-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy
Sponsor: Minoryx Therapeutics, S.L.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module